BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24747691)

  • 1. Molecular monitoring of epithelial-to-mesenchymal transition in breast cancer cells by means of Raman spectroscopy.
    Marro M; Nieva C; Sanz-Pamplona R; Sierra A
    Biochim Biophys Acta; 2014 Sep; 1843(9):1785-95. PubMed ID: 24747691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lipid phenotype of breast cancer cells characterized by Raman microspectroscopy: towards a stratification of malignancy.
    Nieva C; Marro M; Santana-Codina N; Rao S; Petrov D; Sierra A
    PLoS One; 2012; 7(10):e46456. PubMed ID: 23082122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Molecular Basis for Objective Discrimination of Breast Cancer Cells (MCF-7) from Normal Human Mammary Epithelial Cells by Raman Microspectroscopy and Multivariate Curve Resolution Analysis.
    Iwasaki K; Araki A; Krishna CM; Maruyama R; Yamamoto T; Noothalapati H
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indication of high lipid content in epithelial-mesenchymal transitions of breast tissues.
    Sabtu SN; Sani SFA; Looi LM; Chiew SF; Pathmanathan D; Bradley DA; Osman Z
    Sci Rep; 2021 Feb; 11(1):3250. PubMed ID: 33547362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Phases of Breast Cancer Cells: Raman Study of Immortalized, Transformed, and Invasive Cells.
    Chaturvedi D; Balaji SA; Bn VK; Ariese F; Umapathy S; Rangarajan A
    Biosensors (Basel); 2016 Nov; 6(4):. PubMed ID: 27916791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis.
    Mackinder MA; Evans CA; Chowdry J; Staton CA; Corfe BM
    Cancer Biomark; 2012; 12(2):49-64. PubMed ID: 23396250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition.
    Halldorsson S; Rohatgi N; Magnusdottir M; Choudhary KS; Gudjonsson T; Knutsen E; Barkovskaya A; Hilmarsdottir B; Perander M; Mælandsmo GM; Gudmundsson S; Rolfsson Ó
    Cancer Lett; 2017 Jun; 396():117-129. PubMed ID: 28323032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
    Pei XH; Lv XQ; Li HX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminating isogenic cancer cells and identifying altered unsaturated fatty acid content as associated with metastasis status, using k-means clustering and partial least squares-discriminant analysis of Raman maps.
    Hedegaard M; Krafft C; Ditzel HJ; Johansen LE; Hassing S; Popp J
    Anal Chem; 2010 Apr; 82(7):2797-802. PubMed ID: 20187629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XBP1 induces snail expression to promote epithelial- to-mesenchymal transition and invasion of breast cancer cells.
    Li H; Chen X; Gao Y; Wu J; Zeng F; Song F
    Cell Signal; 2015 Jan; 27(1):82-9. PubMed ID: 25280941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines.
    Kondaveeti Y; Guttilla Reed IK; White BA
    Cancer Lett; 2015 Aug; 364(1):44-58. PubMed ID: 25917568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lipid-reactive oxygen species phenotype of breast cancer. Raman spectroscopy and mapping, PCA and PLSDA for invasive ductal carcinoma and invasive lobular carcinoma. Molecular tumorigenic mechanisms beyond Warburg effect.
    Surmacki J; Brozek-Pluska B; Kordek R; Abramczyk H
    Analyst; 2015 Apr; 140(7):2121-33. PubMed ID: 25615557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human breast epithelial cells by confocal Raman microspectroscopy.
    Yu C; Gestl E; Eckert K; Allara D; Irudayaraj J
    Cancer Detect Prev; 2006; 30(6):515-22. PubMed ID: 17113723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cells.
    Lehtinen L; Vainio P; Wikman H; Reemts J; Hilvo M; Issa R; Pollari S; Brandt B; Oresic M; Pantel K; Kallioniemi O; Iljin K
    J Pathol; 2012 Mar; 226(4):674-86. PubMed ID: 22072156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
    Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
    Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells.
    Alsuliman A; Colak D; Al-Harazi O; Fitwi H; Tulbah A; Al-Tweigeri T; Al-Alwan M; Ghebeh H
    Mol Cancer; 2015 Aug; 14():149. PubMed ID: 26245467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of KRAS promotes the mesenchymal features of basal-type breast cancer.
    Kim RK; Suh Y; Yoo KC; Cui YH; Kim H; Kim MJ; Gyu Kim I; Lee SJ
    Exp Mol Med; 2015 Jan; 47(1):e137. PubMed ID: 25633745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
    McCart Reed AE; Kutasovic JR; Vargas AC; Jayanthan J; Al-Murrani A; Reid LE; Chambers R; Da Silva L; Melville L; Evans E; Porter A; Papadimos D; Thompson EW; Lakhani SR; Simpson PT
    J Pathol; 2016 Mar; 238(4):489-94. PubMed ID: 26510554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.